Spirometers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is segmented by Type, Technology, Application, End-User and Geography

Market Snapshot

Spirometers Market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The spirometers market is expected to register a CAGR of 10% over the forecast period of the study which is 2021 - 2026.
The spirometers market will show rapid growth due to the rise in the prevalence of chronic obstructive pulmonary disease (COPD), technological advancements in the field of spirometers and growing preference for home healthcare.

Chronic obstructive pulmonary disease (COPD) is a progressive life-threatening lung disease that causes breathlessness. According to the World Health Organization (WHO), the global burden of disease study reported a prevalence of 251 million cases of COPD, globally, in 2016. It is also estimated that 3.17 million deaths were caused by the disease in 2015, (that is, 5% of all deaths, globally, in that year). However, more than 90% of COPD deaths occur in low and middle-income countries.

The spirometer device thus helps in the identification of different respiratory diseases, such as chronic lung disease that is obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment. Therefore, the rising cases of COPD across the world are thus ultimately increasing the demand of spirometers.

In addition, chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality, globally, there are several studies, which have shown that there is a little awareness of COPD in the general population. However, many individuals with respiratory symptoms were not aware that they need to be diagnosed, which is limiting the use of spirometers, for detecting respiratory devices, which restrict the growth of the market.

Scope of the Report

As per the scope of the report, spirometer is a medical device, which is used to measure the proper functioning of lungs, where the volume of air inhaled and exhaled from the lungs is measured after maximum inhalation by the patient. Spirometer helps in the identification of different respiratory diseases, such as bronchitis, chronic lung diseases that are obstructive, emphysema, asthma, and other breathing diseases, for screening in an occupational environment.  A spirometer is basically used to analyze the lung function before surgery and makes a prediction of the respiratory diseases.

By Type
By Technology
Volume Measurement
Flow Measurement
By Application
Cystic Fibrosis
By End-User
Hospitals and Clinics
Home Healthcare
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Hand-Held is Expected to be the Fastest Growing Segment of the Spirometers Market

The spirometers are likely to witness the fastest growth over the forecast period owing to the ease to use, in both homecare and general practice, by smokers and asthma patients. Therefore with the rapid increase in the prevalence of COPD globally, there is a great demand for spirometers, which is driving many companies to invest more in R&D for innovation of novel and advanced spirometers.

In addition, various technological developments in the mechanism of spirometer are leading to new product developments. The new companies are entering the market, with products, based on innovative technologies.


North America is Found Leading the Spirometers Market

North America has dominated the spirometers market and the dominance of the market is mainly attributable to the increasing prevalence of respiratory diseases. Due to the increasing prevalence of COPD and asthma, there is increased usage of the spirometer, which helps in controlling the disease, and is widely used by the physicians in the hospitals. The United States is also found to be an early adopter of the technologies, which helps in reducing the COPD rates. Hence, with the aforementioned factors, the market is expected to drive in the forecast period.


Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to the market growth. Product innovation and ongoing R&D activities to develop advanced technologies has helped in boosting the growth of the market.

Recent Developments

In April 2021, Vitalograph launched next-generation Pneumotrac spirometer in the United States, along with its upgraded Spirotrac 6 software.

In March 2021, Vyaire Medical launched AioCare mobile spirometry system in more than 15 countries across Europe, the Middle East, and Australia.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in Prevalence of Chronic Obstructive Pulmonary Disease (COPD)

      2. 4.2.2 Technological Advancements in the Field Of Spirometers

      3. 4.2.3 Growing Preference for Home Healthcare

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Awareness regarding Chronic Obstructive Pulmonary Disease (COPD)

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Type

      1. 5.1.1 Hand-Held

      2. 5.1.2 Table-Top

    2. 5.2 By Technology

      1. 5.2.1 Volume Measurement

      2. 5.2.2 Flow Measurement

    3. 5.3 By Application

      1. 5.3.1 Asthma

      2. 5.3.2 COPD

      3. 5.3.3 Cystic Fibrosis

      4. 5.3.4 Others

    4. 5.4 By End-User

      1. 5.4.1 Hospitals and Clinics

      2. 5.4.2 Home Healthcare

    5. 5.5 Geography

      1. 5.5.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.5.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.5.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.5.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle East and Africa

      5. 5.5.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 MGC Diagnostics Corporation

      2. 6.1.2 NDD Medical Technologies

      3. 6.1.3 nSpire Health Inc.

      4. 6.1.4 Philips Healthcare

      5. 6.1.5 Smiths Medical

      6. 6.1.6 Midmark Corporation

      7. 6.1.7 Vyaire Medical Inc.

      8. 6.1.8 OHD (SCHAUENBURG International Group)

      9. 6.1.9 Jones Medical Instrument Company

      10. 6.1.10 Vitalograph

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Spirometers Market market is studied from 2018 - 2026.

The Spirometers Market is growing at a CAGR of 10.0% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

MGC Diagnostics Corporation, NDD Medical Technologies, nSpire Health Inc., Philips Healthcare, Smiths Medical are the major companies operating in Spirometers Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!